Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team
about
Optimal timing and duration of induction therapy for HIV-1 infectionA fossil record of zidovudine resistance in transmitted isolates of HIV-1Genotypic testing for human immunodeficiency virus type 1 drug resistance.Cumulative viral load and virologic decay patterns after antiretroviral therapy in HIV-infected subjects influence CD4 recovery and AIDSEfficacy of zidovudine compared to stavudine, both in combination with lamivudine and indinavir, in human immunodeficiency virus-infected nucleoside-experienced patients with no prior exposure to lamivudine, stavudine, or protease inhibitors (novaviIn vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice.Modelling human immunodeficiency virus ribonucleic acid levels with finite mixtures for censored longitudinal dataStructure-based design and engineering of a nontoxic recombinant pokeweed antiviral protein with potent anti-human immunodeficiency virus activityRecent advances in the treatment of HIV/AIDS.The Genetic Basis of HIV-1 Resistance to Reverse Transcriptase and Protease Inhibitors.Mechanism of HIV antiretroviral drugs progress toward drug resistance.Trends in prevalence of HIV-1 drug resistance in Thailand 2009-2010.
P2860
Q28469250-B79FFF10-1014-465B-A719-83F963622168Q28775685-660AB851-DCED-4588-B857-A3598CC582AAQ33906239-08065835-1A37-4147-AB18-BC3EA2BC0043Q33916321-73248B0B-C286-405F-84C5-B65DE0846E26Q34109417-E7F914FA-382E-430E-A5F5-A020F1278B92Q34141998-E597BF42-31DE-4C0F-840C-0845B04884C2Q34318123-20DEF064-F069-4E2D-90FA-93B924EEACA3Q34734416-789816EB-3D6B-452E-98B6-C6ECA10229BEQ35917365-04B992F7-A43E-4A2B-B7D1-34DAFE419A09Q37018369-D4698523-964F-497B-9CA6-FAD84EC25CEFQ37961181-36240A00-7C53-4413-8D8E-3FE120982FECQ42269396-13737C8B-2C7A-4B9C-873B-F7ABF4F71D72
P2860
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine-lamivudine-ritonavir: genotypic analysis of human immunodeficiency virus type 1 isolates from AIDS clinical trials group protocol 315.ACTG Protocol 315 Team
description
2000 nî lūn-bûn
@nan
2000 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Effect of zidovudine resistanc ...... col 315.ACTG Protocol 315 Team
@ast
Effect of zidovudine resistanc ...... col 315.ACTG Protocol 315 Team
@en
type
label
Effect of zidovudine resistanc ...... col 315.ACTG Protocol 315 Team
@ast
Effect of zidovudine resistanc ...... col 315.ACTG Protocol 315 Team
@en
prefLabel
Effect of zidovudine resistanc ...... col 315.ACTG Protocol 315 Team
@ast
Effect of zidovudine resistanc ...... col 315.ACTG Protocol 315 Team
@en
P2093
P356
P1476
Effect of zidovudine resistanc ...... col 315.ACTG Protocol 315 Team
@en
P2093
Bakhtiari M
Kuritzkes DR
Lederman MM
Spritzler J
St Clair M
P304
P356
10.1086/315244
P407
P577
2000-02-01T00:00:00Z